Collaboration with the private sector has been central to Gavi’s success since its inception. From the outset, Gavi partnered with vaccine manufacturers to secure a reliable supply of quality vaccines at affordable prices for lower-income countries. Today, private sector partners continue to contribute critical funding, expertise, innovation and networks that help advance Gavi’s mission and expand access to life-saving immunisation.

Building on this strong foundation, Gavi seeks to deepen existing partnerships while cultivating new collaborations across industries. By leveraging private sector capabilities, technologies and insights, Gavi aims to drive innovation, enhance efficiency, reduce costs and accelerate progress towards its strategic health and development objectives. These partnerships also play an important role in strengthening country ownership and supporting the long-term sustainability of national immunisation programmes in Gavi-supported countries.

The Vaccine Alliance remains committed to expanding engagement with the private sector through mutually beneficial partnerships that deliver shared value and measurable impact. The Gavi Matching Fund continues to be a highly effective and catalytic mechanism for mobilising private sector investment, expertise and innovation, enabling Gavi to reach more children with life-saving vaccines while strengthening the Alliance’s ability to address evolving global health challenges. In parallel, INFUSE (Innovation for Uptake, Scale and Equity in Immunisation) connects promising private sector innovations with countries and partners to improve vaccine delivery and accelerate the adoption of proven technologies, while the Scale-Up Facility (SUF) helps unlock private capital and technical support to expand successful innovations that have already demonstrated impact across the immunisation value chain. Together, these mechanisms strengthen Gavi’s ability to identify, test and scale breakthrough solutions that improve immunisation outcomes and health system performance.

*'Other donors' includes contributions from foundations, organisations and corporations.

Proceeds to Gavi 6.0 as of 30 June 2026†
Contributions to Gavi Board approved financing instruments

*Local currency

†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.

Contributions and pledges per strategic period (US$ millions)

Hover over the bar chart above to view the data

Direct Contributions (including Matching Fund)

Non-US$ contributions are converted to US$ as follows:

  • Before Gavi 6.0 (2000–2025): exchange rate on date of receipt; where hedged (2014–2025), the hedge rate applies instead.
  • Gavi 6.0 (2026 onward, received & future contributions and Matching Fund Pledges): Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

IFFIm Contributions

Non-US$ contributions are converted to US$ as follows:

  • Received Contributions: rate confirmed by the World Bank's International Bank for Reconstruction and Development (IBRD).
  • Future, signed contribution agreements: exchange rate at time of signing.
  • Future, unsigned contribution agreements: Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

 

All donors